What diseases is acotinib used to treat?

Acalabrutinib (Acalabrutinib) is mainly used to treat B cell lymphoma, especially adults with chronic lymphocytic leukemia (CLL). It is a BTK inhibitor that blocks the proliferation and survival of cancer cells by inhibiting the abnormal signaling pathways in B cells. Acotinib is often used as first-line treatment or as an option when other treatments are ineffective or unsuitable to improve patient survival, symptoms, and quality of life. This drug represents a targeted therapy strategy that targets specific molecules on lymphoma cells, providing patients with a personalized and effective treatment option.